Literature DB >> 9252165

Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis.

T Pollicino1, A R Zanetti, I Cacciola, M A Petit, A Smedile, S Campo, L Sagliocca, M Pasquali, E Tanzi, G Longo, G Raimondo.   

Abstract

Controversial data were recently published concerning the association of hepatitis B virus (HBV) variants with fulminant hepatitis (FH). In this study, we first analyzed the complete nucleotide sequences of HBV genomes isolated from serum samples from a surgeon and his mother, who was accidentally infected by the son; both died of FH. The infecting viruses were genetically almost identical in both patients; all the clones examined carried a double nucleotide mutation in the start codon of the pre-S2 region that prevented the synthesis of the corresponding protein. Analyses of different serum samples from the son revealed only wild-type precore sequences in a high viremic serum, whereas hepatitis B e antigen (HBeAg)-defective strains were prevalent when the viremia had decreased. Subsequently, we extended the analysis to the viral genomes isolated from 18 additional patients with acute HBV infection and different clinical behaviors: 3 of 5 patients with FH and without previous liver disease had pre-S2 start codon mutations preventing pre-S2 protein synthesis, whereas none of the 13 control cases had similar genomic rearrangements. Analysis of the precore region showed that viral populations normally producing HBeAg were the only or the prevalent viral strains in all of these cases. In summary, our results support the hypothesis that the pre-S2 protein is not essential for HBV infectivity. They also show that infection by pre-S2-defective virus is frequently associated with FH, indicating that this variant might play a pathogenetic role in cases of acute liver failure. Finally, they suggest that the emergence of HBeAg-defective viruses might be a late event in the course of FH, occurring when HBeAg-producing viruses have been mostly cleared.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252165     DOI: 10.1002/hep.510260235

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen.

Authors:  T T Yuan; G K Sahu; W E Whitehead; R Greenberg; C Shih
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen.

Authors:  T T Yuan; P C Tai; C Shih
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 3.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

4.  Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.

Authors:  Li-Shuai Qu; Jin-Xia Liu; Tao-Tao Liu; Xi-Zhong Shen; Tao-Yang Chen; Zheng-Pin Ni; Cui-Hua Lu
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

5.  Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure.

Authors:  Zhaochun Chen; Giacomo Diaz; Teresa Pollicino; Huaying Zhao; Ronald E Engle; Peter Schuck; Chen-Hsiang Shen; Fausto Zamboni; Zhifeng Long; Juraj Kabat; Davide De Battista; Kevin W Bock; Ian N Moore; Kurt Wollenberg; Cinque Soto; Sugantha Govindarajan; Peter D Kwong; David E Kleiner; Robert H Purcell; Patrizia Farci
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

6.  Management of hepatitis B virus-related acute liver failure.

Authors:  Makoto Oketani; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi
Journal:  Clin J Gastroenterol       Date:  2014-01-24

Review 7.  Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.

Authors:  Osamu Yokosuka; Makoto Arai
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

8.  Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.

Authors:  Tao Bian; Hongxia Yan; Liping Shen; Feng Wang; Shuang Zhang; Yanqiang Cao; Shuo Zhang; Yong Zhang; Shengli Bi
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

9.  Molecular epidemiology of an outbreak of fulminant hepatitis B.

Authors:  N Petrosillo; G Ippolito; L Solforosi; P E Varaldo; M Clementi; A Manzin
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

10.  Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

Authors:  Jeong Han Kim; Young Kul Jung; Moon Kyung Joo; Ji Hoon Kim; Hyung Joon Yim; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak; Jong Eun Yeon; Kwan Soo Byun
Journal:  J Korean Med Sci       Date:  2009-01-19       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.